...
首页> 外文期刊>Chemical and Pharmaceutical Bulletin >Preparation, Optimization and Characteristic of Huperzine A Loaded Nanostructured Lipid Carriers
【24h】

Preparation, Optimization and Characteristic of Huperzine A Loaded Nanostructured Lipid Carriers

机译:石杉碱甲载纳米结构脂质载体的制备,优化及性能

获取原文

摘要

The objective of the present work was to study the preparation, optimization and characteristics of Huperzine A (Hup A), an effective Traditional Chinese Medicine treatment of Alzheimer's disease (AD), loaded nanostructured lipid carriers (NLC). NLC were successfully prepared by a modified method of melt ultrasonication followed by high pressure homogenization using Cetyl Palmitate (CP) as the solid lipid, Miglyol?812 as the liquid lipid, Soybean phosphatidylcholine (Spc) and Solutol HS15? as the emulsifiers. The best formulation was optimized with a three-factor, three-level Box–Behnken design. Independent variables studied were the amount of the mixed lipid, the amount of the emulsifier mixture and lipid/drug ratio in the formulation. The dependent variables were the particle size, entrapment efficiency (EE) and drug loading (DL). Properties of NLC such as the morphology, particle size, zeta potential, EE, DL and drug release behavior were investigated, respectively. As a result, the designed nanoparticles showed nearly spherical particles with a mean particle size of 120 nm and ?22.93±0.91 mV. The EE (%) and DL (%) could reach up to 89.18±0.28% and 1.46±0.05%, respectively. Differential scanning calorimetry (DSC) of Hup A loaded NLC indicated no tendency of recrystallisation. In vitro release studies showed a burst release at the initial stage and followed by a prolonged release of Hup A from NLC up to 96 h. The results suggest that the presented Hup A loaded NLC system is a potential delivery system for improving drug loading capacity and controlled drug release.
机译:本工作的目的是研究石杉碱甲(Hup A)的制备,优化和特性,石杉碱甲是一种有效的中药治疗阿尔茨海默氏病(AD),负载有纳米结构脂质载体(NLC)。通过改进的熔融超声方法,然后使用棕榈酸十六烷基酯(CP)作为固体脂质,Miglyol ? 812作为液体脂质,大豆磷脂酰胆碱(Spc)和Solutol HS15进行高压均质化,成功制备了NLC ?作为乳化剂。最佳配方通过三因素,三级Box–Behnken设计进行了优化。研究的独立变量是混合脂质的量,乳化剂混合物的量和制剂中的脂质/药物比。因变量是粒径,包封率(EE)和载药量(DL)。分别研究了NLC的性质,如形态,粒径,ζ电势,EE,DL和药物释放行为。结果,设计的纳米颗粒显示出接近球形的颗粒,其平均粒径为120 nm,λ22.93±0.91 mV。 EE(%)和DL(%)分别可达89.18±0.28%和1.46±0.05%。装有Hup A的NLC的差示扫描量热法(DSC)表明没有重结晶的趋势。体外释放研究表明,在初始阶段爆发性释放,随后Hup A从NLC持续释放长达96小时。结果表明,所提出的HupA负载的NLC系统是用于改善药物负载能力和控制药物释放的潜在输送系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号